| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-03 15:39 Tx date 2022-05-30 |
$TBP
Tetra Bio-Pharma Inc. |
Auld, Leslie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-03 15:38 Tx date 2022-05-30 |
$TBP
Tetra Bio-Pharma Inc. |
Auld, Leslie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-22 11:54 Tx date 2021-12-21 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$68,250
+350,000 vol $0.195 each |
425,000 | |
| Filed 2021-12-22 11:52 Tx date 2021-12-21 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$57,050
+350,000 vol $0.163 each |
496,000 | |
| Filed 2021-06-03 17:43 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-03 17:41 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Kim, John
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-02 14:45 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Norton, Brent
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
46 - Compensation for services
|
$49,999
+140,845 vol $0.355 each |
404,002 | |
| Filed 2021-06-02 12:58 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-02 12:55 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-01 23:31 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 23:24 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 20:04 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 20:04 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-06-01 20:03 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 20:03 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 20:03 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 20:02 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
AULD, CATHERINE ANNE
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-06-01 19:53 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|